• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双色抗体微阵列的归一化方法评估和优化。

Assessment and optimisation of normalisation methods for dual-colour antibody microarrays.

机构信息

Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.

出版信息

BMC Bioinformatics. 2010 Nov 12;11:556. doi: 10.1186/1471-2105-11-556.

DOI:10.1186/1471-2105-11-556
PMID:21073702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098099/
Abstract

BACKGROUND

Recent advances in antibody microarray technology have made it possible to measure the expression of hundreds of proteins simultaneously in a competitive dual-colour approach similar to dual-colour gene expression microarrays. Thus, the established normalisation methods for gene expression microarrays, e.g. loess regression, can in principle be applied to protein microarrays. However, the typical assumptions of such normalisation methods might be violated due to a bias in the selection of the proteins to be measured. Due to high costs and limited availability of high quality antibodies, the current arrays usually focus on a high proportion of regulated targets. Housekeeping features could be used to circumvent this problem, but they are typically underrepresented on protein arrays. Therefore, it might be beneficial to select invariant features among the features already represented on available arrays for normalisation by a dedicated selection algorithm.

RESULTS

We compare the performance of several normalisation methods that have been established for dual-colour gene expression microarrays. The focus is on an invariant selection algorithm, for which effective improvements are proposed. In a simulation study the performances of the different normalisation methods are compared with respect to their impact on the ability to correctly detect differentially expressed features. Furthermore, we apply the different normalisation methods to a pancreatic cancer data set to assess the impact on the classification power.

CONCLUSIONS

The simulation study and the data application demonstrate the superior performance of the improved invariant selection algorithms in comparison to other normalisation methods, especially in situations where the assumptions of the usual global loess normalisation are violated.

摘要

背景

抗体微阵列技术的最新进展使得以类似于双色基因表达微阵列的竞争性双色方法同时测量数百种蛋白质的表达成为可能。因此,基因表达微阵列的既定标准化方法,例如局部加权回归,可以原则上应用于蛋白质微阵列。然而,由于在选择要测量的蛋白质时存在偏差,这种标准化方法的典型假设可能会被违反。由于高成本和高质量抗体的有限可用性,当前的阵列通常侧重于高度调控的靶标。管家功能可以用来解决这个问题,但是它们在蛋白质阵列上的代表性通常不足。因此,通过专门的选择算法,选择在现有阵列上已经表示的特征中的不变特征进行归一化可能是有益的。

结果

我们比较了几种已为双色基因表达微阵列建立的标准化方法的性能。重点是一种不变选择算法,并针对该算法提出了有效的改进。在模拟研究中,比较了不同归一化方法在正确检测差异表达特征的能力方面的性能。此外,我们将不同的归一化方法应用于胰腺癌数据集,以评估其对分类能力的影响。

结论

模拟研究和数据应用表明,改进的不变选择算法在与其他归一化方法相比具有优越的性能,尤其是在通常的全局局部加权回归归一化的假设被违反的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/f4900ead0e47/1471-2105-11-556-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/03ddafcab02a/1471-2105-11-556-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/4eeb2f141af0/1471-2105-11-556-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/2f6996772833/1471-2105-11-556-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/b76901842669/1471-2105-11-556-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/baa2ed7f8140/1471-2105-11-556-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/f4900ead0e47/1471-2105-11-556-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/03ddafcab02a/1471-2105-11-556-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/4eeb2f141af0/1471-2105-11-556-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/2f6996772833/1471-2105-11-556-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/b76901842669/1471-2105-11-556-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/baa2ed7f8140/1471-2105-11-556-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b285/3098099/f4900ead0e47/1471-2105-11-556-6.jpg

相似文献

1
Assessment and optimisation of normalisation methods for dual-colour antibody microarrays.双色抗体微阵列的归一化方法评估和优化。
BMC Bioinformatics. 2010 Nov 12;11:556. doi: 10.1186/1471-2105-11-556.
2
BABAR: an R package to simplify the normalisation of common reference design microarray-based transcriptomic datasets.BABAR:一个 R 包,用于简化常见参考设计微阵列转录组数据集的标准化。
BMC Bioinformatics. 2010 Feb 3;11:73. doi: 10.1186/1471-2105-11-73.
3
Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays.抗体微阵列的实验设计与分析:应用来自cDNA阵列的方法
Cancer Res. 2005 Apr 15;65(8):2985-9. doi: 10.1158/0008-5472.CAN-04-3213.
4
There is no silver bullet--a guide to low-level data transforms and normalisation methods for microarray data.没有万灵药——微阵列数据的低层次数据转换与归一化方法指南
Brief Bioinform. 2005 Mar;6(1):86-97. doi: 10.1093/bib/6.1.86.
5
A comparison on effects of normalisations in the detection of differentially expressed genes.差异表达基因检测中标准化方法效果的比较。
BMC Bioinformatics. 2009 Feb 13;10:61. doi: 10.1186/1471-2105-10-61.
6
Replication, variation and normalisation in microarray experiments.微阵列实验中的复制、变异与标准化
Appl Bioinformatics. 2005;4(1):33-44. doi: 10.2165/00822942-200504010-00004.
7
Cross-platform microarray data normalisation for regulatory network inference.跨平台微阵列数据标准化用于调控网络推断。
PLoS One. 2010 Nov 12;5(11):e13822. doi: 10.1371/journal.pone.0013822.
8
Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides.双色寡核苷酸点阵微阵列载玻片标准化技术的临床验证基准测试。
Appl Bioinformatics. 2003;2(4):219-28.
9
Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays.在表达谱分析中交互式优化信噪比:Affymetrix微阵列中特定项目的算法选择和检测p值加权
Bioinformatics. 2004 Nov 1;20(16):2534-44. doi: 10.1093/bioinformatics/bth280. Epub 2004 Apr 29.
10
Comparative study of classification algorithms for immunosignaturing data.免疫特征数据分类算法的比较研究。
BMC Bioinformatics. 2012 Jun 21;13:139. doi: 10.1186/1471-2105-13-139.

引用本文的文献

1
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease.预测进展为重症 COVID-19 疾病的早期生物标志物的发现与系统评估。
Commun Med (Lond). 2023 Apr 12;3(1):51. doi: 10.1038/s43856-023-00283-z.
2
Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis.抗体阵列鉴定出腹膜子宫内膜异位症的周期依赖性血浆生物标志物候选物。
J Pers Med. 2022 May 24;12(6):852. doi: 10.3390/jpm12060852.
3
Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.

本文引用的文献

1
Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.用包含 810 种癌症相关抗体的微阵列对复杂样本进行双色蛋白质组学分析。
Mol Cell Proteomics. 2010 Jun;9(6):1271-80. doi: 10.1074/mcp.M900419-MCP200. Epub 2010 Feb 16.
2
Oncoproteomic profiling with antibody microarrays.抗体微阵列的癌蛋白质组学分析。
Genome Med. 2009 Jul 6;1(7):68. doi: 10.1186/gm68.
3
Microarray background correction: maximum likelihood estimation for the normal-exponential convolution.微阵列背景校正:正态-指数卷积的最大似然估计
蛋白质组学分析腹膜液发现 COMP 和 TGFBI 是子宫内膜异位症的新候选生物标志物。
Sci Rep. 2021 Oct 22;11(1):20870. doi: 10.1038/s41598-021-00299-2.
4
Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.二甲双胍处理和高胰岛素血症引起的人子宫内膜癌细胞系中蛋白质表达的变化。
PLoS One. 2021 Mar 9;16(3):e0248103. doi: 10.1371/journal.pone.0248103. eCollection 2021.
5
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.巨噬细胞衍生的白细胞介素 1β和肿瘤坏死因子α调节神经母细胞瘤中的精氨酸代谢。
Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13.
6
Personalised proteome analysis by means of protein microarrays made from individual patient samples.基于个体患者样本的蛋白质微阵列进行个体化蛋白质组分析。
Sci Rep. 2017 Jan 3;7:39756. doi: 10.1038/srep39756.
7
Data Analysis Strategies for Protein Microarrays.蛋白质微阵列的数据分析策略
Microarrays (Basel). 2012 Aug 6;1(2):64-83. doi: 10.3390/microarrays1020064.
8
Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.西妥昔单抗治疗后结直肠癌细胞与其外泌体之间miRNA和蛋白质的高度偏态分布:生物分子、遗传及转化意义
Oncoscience. 2014 Mar 16;1(2):132-157. doi: 10.18632/oncoscience.19. eCollection 2014.
9
A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma.一种系统生物学方法,用于描述导致黏液样脂肪肉瘤体外模型中 trabectedin 耐药的调控网络。
PLoS One. 2012;7(4):e35423. doi: 10.1371/journal.pone.0035423. Epub 2012 Apr 16.
Biostatistics. 2009 Apr;10(2):352-63. doi: 10.1093/biostatistics/kxn042. Epub 2008 Dec 8.
4
Antibodypedia, a portal for sharing antibody and antigen validation data.抗体百科,一个用于分享抗体和抗原验证数据的平台。
Mol Cell Proteomics. 2008 Oct;7(10):2028-37. doi: 10.1074/mcp.M800264-MCP200. Epub 2008 Jul 29.
5
Using generalized procrustes analysis (GPA) for normalization of cDNA microarray data.使用广义普罗克汝斯分析(GPA)对cDNA微阵列数据进行标准化处理。
BMC Bioinformatics. 2008 Jan 16;9:25. doi: 10.1186/1471-2105-9-25.
6
Antibody microarray analysis of directly labelled complex proteomes.直接标记的复杂蛋白质组的抗体微阵列分析
Curr Opin Biotechnol. 2008 Feb;19(1):55-61. doi: 10.1016/j.copbio.2007.11.010. Epub 2008 Jan 9.
7
High-throughput proteomics using antibody microarrays: an update.使用抗体微阵列的高通量蛋白质组学:最新进展
Expert Rev Mol Diagn. 2007 Sep;7(5):673-86. doi: 10.1586/14737159.7.5.673.
8
A comparison of background correction methods for two-colour microarrays.双色微阵列背景校正方法的比较
Bioinformatics. 2007 Oct 15;23(20):2700-7. doi: 10.1093/bioinformatics/btm412. Epub 2007 Aug 25.
9
Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins.用于血清蛋白谱分析的重组抗体微阵列设计:补体蛋白的靶向研究
J Proteome Res. 2007 Sep;6(9):3527-36. doi: 10.1021/pr070204f. Epub 2007 Aug 16.
10
Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies.基于抗体微阵列的复杂样本分析:标记策略的系统评估
Proteomics. 2007 Jun;7(11):1786-99. doi: 10.1002/pmic.200600762.